Gagliardi M, Galasso M, Garofalo I, Uccello G, Morosato M, Pera I
Cardiovasc Interv Ther. 2025; .
PMID: 40059134
DOI: 10.1007/s12928-025-01106-9.
Nama G, Nadeem M
Cureus. 2025; 16(12):e75346.
PMID: 39791078
PMC: 11711242.
DOI: 10.7759/cureus.75346.
Karanikola A, Soulaidopoulos S, Leontsinis I, Dri E, Sagris M, Kordalis A
Life (Basel). 2025; 14(12.
PMID: 39768297
PMC: 11678317.
DOI: 10.3390/life14121590.
Guedeney P, Rodes-Cabau J, Ten Berg J, Windecker S, Angiolillo D, Montalescot G
EuroIntervention. 2024; 20(16):972-986.
PMID: 39155752
PMC: 11317833.
DOI: 10.4244/EIJ-D-23-01084.
Poulin M, Kavinsky C
J Soc Cardiovasc Angiogr Interv. 2024; 3(7):102145.
PMID: 39132003
PMC: 11307763.
DOI: 10.1016/j.jscai.2024.102145.
Atrial function after percutaneous occluder device and suture-mediated patent fossa ovalis closure.
Tarsia C, Gaspardone C, De Santis A, DAscoli E, Piccioni F, Sgueglia G
Eur Heart J Imaging Methods Pract. 2024; 2(1):qyae008.
PMID: 39045174
PMC: 11195760.
DOI: 10.1093/ehjimp/qyae008.
Updates on Patent Foramen Ovale (PFO) Closure.
Voudris K, Poulin M, Kavinsky C
Curr Cardiol Rep. 2024; 26(7):735-746.
PMID: 38913234
DOI: 10.1007/s11886-024-02073-y.
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC.
Ntaios G, Baumgartner H, Doehner W, Donal E, Edvardsen T, Healey J
Eur Heart J. 2024; 45(19):1701-1715.
PMID: 38685132
PMC: 11107123.
DOI: 10.1093/eurheartj/ehae150.
Patent Foramen Ovale: The Unresolved Questions.
Forzano I, Santulli G
Top Ital Sci J. 2024; 1(2).
PMID: 38585657
PMC: 10995646.
DOI: 10.62684/DMFZ6956.
Multimodal Cardiac Imaging in the Assessment of Patients Who Have Suffered a Cardioembolic Stroke: A Review.
Thong E, Kong W, Poh K, Wong R, Chai P, Sia C
J Cardiovasc Dev Dis. 2024; 11(1).
PMID: 38248883
PMC: 10816708.
DOI: 10.3390/jcdd11010013.
Patent Foramen Ovale Percutaneous Closure: Evolution and Ongoing Challenges.
Devos P, Guedeney P, Montalescot G
J Clin Med. 2024; 13(1).
PMID: 38202061
PMC: 10780039.
DOI: 10.3390/jcm13010054.
Large regional variation in cardiac closure procedures to prevent ischemic stroke in Switzerland a population-based small area analysis.
Stoller N, Wertli M, Haynes A, Chiolero A, Rodondi N, Panczak R
PLoS One. 2024; 19(1):e0291299.
PMID: 38166018
PMC: 10760725.
DOI: 10.1371/journal.pone.0291299.
Incidence of atrial fibrillation in cryptogenic stroke with patent foramen ovale closure: protocol for the prospective, observational PFO-AF study.
Badoz M, Derimay F, Serzian G, Besutti M, Rioufol G, Frey P
BMJ Open. 2023; 13(9):e074584.
PMID: 37699623
PMC: 10503323.
DOI: 10.1136/bmjopen-2023-074584.
New-onset atrial fibrillation after percutaneous patent foramen ovale closure: a meta-analysis.
Jurczyk D, Macherey-Meyer S, Rawish E, Stiermaier T, Eitel I, Frerker C
Clin Res Cardiol. 2023; 112(12):1824-1834.
PMID: 37515604
PMC: 10697880.
DOI: 10.1007/s00392-023-02263-8.
Unexpected paradoxical embolization following catheter-directed thrombectomy with the FlowTriever™ system in a patient with pulmonary embolism: a case report.
Uecker N, Rosenkranz S, Bunck A, Tichelbacker T
Eur Heart J Case Rep. 2023; 7(3):ytad074.
PMID: 36895302
PMC: 9991041.
DOI: 10.1093/ehjcr/ytad074.
Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.
Testa L, Popolo Rubbio A, Squillace M, Albano F, Cesario V, Casenghi M
Front Cardiovasc Med. 2023; 9:1064026.
PMID: 36712245
PMC: 9875285.
DOI: 10.3389/fcvm.2022.1064026.
Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome.
Kefer J, Carbonez K, Pierard S, Mouthuy F, Peeters A, Hermans C
J Interv Cardiol. 2022; 2022:6559447.
PMID: 36348991
PMC: 9633204.
DOI: 10.1155/2022/6559447.
Establishment of the Heart and Brain Team for Patent Foramen Ovale Closure in Stroke Patients: An Expert Opinion.
Kim J, Thijs V, Yudi M, Toyoda K, Shiozawa M, Zening J
J Stroke. 2022; 24(3):345-351.
PMID: 36221937
PMC: 9561221.
DOI: 10.5853/jos.2022.02103.
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin.
Rubiera M, Aires A, Antonenko K, Lemeret S, Nolte C, Putaala J
Eur Stroke J. 2022; 7(3):VI.
PMID: 36082257
PMC: 9446336.
DOI: 10.1177/23969873221099478.
Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke.
Diener H, Wachter R, Wong A, Thijs V, Schnabel R, Ntaios G
Int J Stroke. 2022; 18(4):400-407.
PMID: 36050817
PMC: 10037544.
DOI: 10.1177/17474930221124412.
